BridgeMD
New treatment option for Thoracic Surgery
Official title Respiratory Rehabilitation Based on Eccentric Exercice on Treadmill After Thoracic Surgery
ClinicalTrials.gov ID: NCT06493877
What this study is testing
- What it's testing
- Thoracic surgeries are frequent and pulmonary rehabilitation is essential, since one of the problems that these patients present is dyspnea when performing aerobic exercise, which limits improvement and in some cases causes them to abandon physical exercise. Thanks to carrying out a correct effort retraining program, combining respiratory physiotherapy with therapeutic exercise, patients with respiratory pathologies manage to improve lung capacity and ventilatory mechanics, increase muscle strength and aerobic resistance, prevent long- term complications, reduce fatigue and, ultimately, improve your quality of life.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- people \>18 years.
- Thoracic surgery in the previous 75 days
- Present dyspnea grade 2 - 3 on the mMRC scale.
- Cognitive and functional level sufficient to understand, learn and carry out the exercise program.
- Not have contraindications to perform physical training.
You likely can't join if
- Severe intolerance to exertion due to untreated cardiac arrhythmias, ischemia during low intensity exercise (anginas unstable), severe pulmonary...
- Pulmonary embolism with anticoagulant treatment less than 5 days.
- Recent cardiovascular events such as congestive heart failure, angioplasties or cardiac surgeries of less than four weeks' duration, valvular...
- Kidney failure requiring dialysis.
- Patients with uncontrolled bronchospasm due to intrinsic asthma.
- Patients undergoing post-surgery chemotherapy treatment.
See the full eligibility criteria
- people \>18 years.
- Thoracic surgery in the previous 75 days
- Present dyspnea grade 2 - 3 on the mMRC scale.
- Cognitive and functional level sufficient to understand, learn and carry out the exercise program.
- Not have contraindications to perform physical training.
- Active collaborators.
- Severe intolerance to exertion due to untreated cardiac arrhythmias, ischemia during low intensity exercise (anginas unstable), severe pulmonary hypertension, heart failure (NYHA III or IV)
- Pulmonary embolism with anticoagulant treatment less than 5 days.
- Recent cardiovascular events such as congestive heart failure, angioplasties or cardiac surgeries of less than four weeks' duration, valvular alterations requiring surgical correction, myopericarditis, ventricular...
- Kidney failure requiring dialysis.
- Patients with uncontrolled bronchospasm due to intrinsic asthma.
- Patients undergoing post-surgery chemotherapy treatment.
- Adverse effects that occurred during the development of the treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.